GSK
GSK
GSK
804 hedge funds and large institutions have $12B invested in GSK in 2019 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 279 increasing their positions, 284 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.05% more ownership
Funds ownership: 4.48% → 4.53% (+0.05%)
0% more funds holding in top 10
Funds holding in top 10: 14 → 14 (0)
2% less repeat investments, than reductions
Existing positions increased: 279 | Existing positions reduced: 284
Holders
804
Holding in Top 10
14
Calls
$147M
Puts
$115M
Top Buyers
| 1 | +$97.7M | |
| 2 | +$80.3M | |
| 3 | +$63.5M | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$60.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.5M |
Top Sellers
| 1 | -$58.2M | |
| 2 | -$56.8M | |
| 3 | -$51.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$45.5M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$43.4M |